A61P 5/08
For decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Official title: for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
A61P5/08 (For decreasing, blocking or antagonising the activity of the anterior pituitary hormones) appears on 183 US grants and 285 published applications in this corpus.
Search patents in A61P- Granted patents
- 183
- Published applications
- 285
- Assignees
- 134
- Inventors
- 539
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 2 |
| 2002 | 3 | 1 |
| 2003 | 4 | 10 |
| 2004 | 5 | 17 |
| 2005 | 2 | 12 |
| 2006 | 7 | 21 |
| 2007 | 10 | 13 |
| 2008 | 10 | 8 |
| 2009 | 8 | 19 |
| 2010 | 9 | 17 |
| 2011 | 7 | 14 |
| 2012 | 11 | 12 |
| 2013 | 10 | 14 |
| 2014 | 4 | 11 |
| 2015 | 7 | 7 |
| 2016 | 13 | 16 |
| 2017 | 10 | 12 |
| 2018 | 5 | 7 |
| 2019 | 4 | 8 |
| 2020 | 5 | 14 |
| 2021 | 3 | 8 |
| 2022 | 4 | 15 |
| 2023 | 2 | 4 |
| 2024 | 4 | 4 |
| 2025 | 2 | 11 |
| 2026 | 5 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-surgical prevention of unpleasant odor in meats and aggressive or sexual behavior in male ruminants28 Jul 2026US 12,691,126 B2Insigna Inc.
- Concomitant administration of glucocorticoid receptor modulator relacorilant and CYP2C9 substrates5 May 2026US 12,616,685 B2Corcept Therapeutics, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors17 Mar 2026US 12,576,084 B2Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors10 Mar 2026US 12,569,490 B2Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors10 Mar 2026US 12,569,491 B2Spruce Biosciences, Inc.
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248795 A1Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248796 A1Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248797 A1Spruce Biosciences, Inc.
- Methods for treating testicular and ovarian adrenal rest tumors27 Aug 2026US 2026/0248798 A1Spruce Biosciences, Inc.
Most cited
By later US patents
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease169US 5,883,113 ASugen, Inc. · 1999
- 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease168US 5,886,020 ASugen, Inc. · 1999
- 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease165US 5,834,504 ASugen, Inc. · 1998
- Human growth hormone variants153US 5,849,535 AGenentech, Inc. · 1998